NCT00036569 2012-02-13A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine GliomasNational Institutes of Health Clinical Center (CC)Phase 2 Completed32 enrolled 12 charts